Materials Healthcare Sector

AppYea

Market Cap: US$5.9m

A digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring.

Unified Global

Market Cap: US$5.9m

Operates as a vertically integrated cannabis company in Canada and the United States.

GENinCode

Market Cap: UK£4.4m

Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.

Channel Therapeutics

Market Cap: US$5.9m

A clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.

MetaVia

Market Cap: US$5.8m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

Genprex

Market Cap: US$5.7m

A clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs.

Kovo+ Holdings

Market Cap: CA$8.0m

Operates as a healthcare technology company.

Lipella Pharmaceuticals

Market Cap: US$5.7m

A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.

GT Biopharma

Market Cap: US$5.7m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Sigyn Therapeutics

Market Cap: US$5.7m

A development-stage company, provides therapeutic solutions to treat cancer and infectious disease disorders in the United States.

Mobile-health Network Solutions

Market Cap: US$5.6m

An investment holding company, provides telehealth solutions primarily in Singapore.

Klotho Neurosciences

Market Cap: US$5.6m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

Traws Pharma

Market Cap: US$5.6m

A clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.

AEON Biopharma

Market Cap: US$5.6m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

Sproutly Canada

Market Cap: CA$7.6m

Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.

Argent BioPharma

Market Cap: AU$8.7m

A multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide.

Univec

Market Cap: US$5.5m

Provides health care services in the United States.

Cardiac Biotech Solutions

Market Cap: US$5.5m

Through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally.

Frequency Exchange

Market Cap: CA$7.6m

Focuses on the development and commercialization of a wearable frequency delivery system for the health and wellness market.

StateHouse Holdings

Market Cap: CA$7.7m

An integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.

FutureNet

Market Cap: US$5.4m

This record represents the public shell of FutureNet Inc.

Check-Cap

Market Cap: US$5.3m

A clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Burzynski Research Institute

Market Cap: US$5.3m

Engages in the research and development of antineoplaston drugs for the treatment of various cancers.

ProText Mobility

Market Cap: US$5.3m

A biotech company, engages in the development of pharmaceutical botanical medicines.

BioCorRx

Market Cap: US$5.3m

Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.

N4 Pharma

Market Cap: UK£4.0m

A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.

American Films

Market Cap: US$5.2m

Does not have significant operations.

Quantumzyme

Market Cap: US$5.2m

Operates as a biotransformation company.

Pasithea Therapeutics

Market Cap: US$5.2m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

Sonoma Pharmaceuticals

Market Cap: US$5.1m

Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

HITIQ

Market Cap: AU$8.0m

Engages in development and commercialization of concussion management technology and software in Australia.

Apollomics

Market Cap: US$5.1m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer.

Belluscura

Market Cap: UK£3.8m

Develops and commercialize oxygen related medical device products in the United States.

Vycor Medical

Market Cap: US$5.1m

Designs, develops, and markets neurological medical devices and therapies in the United States and Europe.

CordovaCann

Market Cap: US$5.1m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

Rakovina Therapeutics

Market Cap: CA$7.0m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.